Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.

Episode 83: Retinopathy of Prematurity: Has Anti-VEGF Changed the Game?


Anti-VEGF has transformed how we treat retinopathy of prematurity — but at what long-term cost? Dr. Kanmin Xue (UK) chairs a global discussion with Dr. Domenico Lepore (Italy), Prof. Wei-Chi Wu (Taiwan) and Prof. Andreas Stahl (Germany) on injections versus laser, the RAINBOW and FIREFLEYE trial data, managing peripheral avascular retina, and why these babies may need follow-up for life. A frank look at the questions the evidence hasn’t yet answered.

Members can continue the conversation in the Euretina Forum.

Browse all podcast episodes here.

Listen on your preferred podcast player:

Listen on your preferred podcast player:

IMPORTANT INFORMATION

Beware of fraudulent websites, emails and hotel booking offers

www.euretina.org is the only official website of the European Society of Retina Specialists.
 
Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.
 
This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.
 
If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].